VAPO has been the topic of a number of other reports. William Blair cut Vapotherm from an “outperform” rating to a “market perform” rating in a research report on Thursday. Canaccord Genuity Group downgraded Vapotherm from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $12.00 to $5.00 in a research note on Friday, May 6th. Canaccord Genuity Group lowered Vapotherm from a “buy” rating to a “hold” rating and decreased their price target for the company from $12.00 to $5.00 in a report on Friday, May 6th. Finally, Piper Sandler lowered their price target on Vapotherm from $2.50 to $2.00 and set an “underweight” rating for the company in a research report on Thursday. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the stock. According to data from MarketBeat, Vapotherm presently has a consensus rating of “Hold” and an average target price of $4.75.
Vapotherm Price Performance
VAPO opened at $1.80 on Thursday. Vapotherm has a 12-month low of $1.66 and a 12-month high of $31.87. The company has a current ratio of 5.37, a quick ratio of 3.75 and a debt-to-equity ratio of 1.79. The stock has a fifty day simple moving average of $2.56 and a two-hundred day simple moving average of $7.93. The company has a market cap of $47.82 million, a price-to-earnings ratio of -0.49 and a beta of -0.22.
Insider Activity at Vapotherm
In related news, Director James W. Liken purchased 10,000 shares of the firm’s stock in a transaction on Wednesday, May 11th. The stock was bought at an average cost of $2.98 per share, with a total value of $29,800.00. Following the completion of the acquisition, the director now owns 134,378 shares of the company’s stock, valued at approximately $400,446.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have bought a total of 40,000 shares of company stock worth $122,700 over the last quarter. Insiders own 12.80% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. Adage Capital Partners GP L.L.C. lifted its stake in Vapotherm by 12.5% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 450,000 shares of the company’s stock worth $9,320,000 after acquiring an additional 50,000 shares in the last quarter. Crow s Nest Holdings LP purchased a new stake in shares of Vapotherm in the fourth quarter valued at approximately $11,422,000. Sio Capital Management LLC purchased a new stake in shares of Vapotherm in the fourth quarter valued at approximately $3,728,000. RiverVest Venture Management LLC raised its holdings in Vapotherm by 0.6% during the fourth quarter. RiverVest Venture Management LLC now owns 407,166 shares of the company’s stock worth $8,432,000 after purchasing an additional 2,535 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC acquired a new position in Vapotherm during the fourth quarter worth $10,339,000. 69.67% of the stock is owned by institutional investors and hedge funds.
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
- Get a free copy of the StockNews.com research report on Vapotherm (VAPO)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.